The largest database of trusted experimental protocols

3 protocols using ab108921

1

Co-Immunoprecipitation of NPC1 Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
Co-IP for NPC1 was performed using 50 μl of the Immobilized Recombinant Protein G Resin (Generon) and specific antibodies against NPC1 (Abcam, ab108921) as previously described (García-Dorival et al., 2016 (link)). The cell pellets were incubated for 30 min on ice with 200 μl lysis buffer. The lysate was then clarified by centrifugation and diluted five-fold with dilution buffer prior to adding 2 μg of the primary antibody and then incubated at 4 °C on a rotator for 2 h. The protein G resin (Generon) were equilibrated with ice-cold dilution buffer and then incubated at 4 °C on a rotator with diluted cell lysate containing the antibody overnight at 4 °C on a rotator, followed by centrifugation at 2500×g for 2 min to remove non-bounds fractions. The wash and elution steps were performed as described previously for GFP co-immunoprecipitation.
+ Open protocol
+ Expand
2

Cholesterol Trafficking and Lysosomal Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chemical and standard reagents including filipin and NBD-cholesterol were obtained from Sigma-Aldrich, St. Louis, MO. LysoTracker and fluorescent dextran were obtained from Life Technologies (Grand Island, NY). shRNA constructs were obtained from SA Biosciences (Valencia, CA). Antibodies against tubulin [1:100 for immunofluorescence (IF), T6199, Sigma-Aldrich], EGFP (1:100 for IF, 632380, Clontech) and mCherry (1:100 for IF, NBP1-96752, Novus Biologicals) have been described previously (Whyte et al., 2008 (link); Towns et al., 2009 (link)). Antibodies against StARD9 [1:100 for western blotting (WB), HPA014562] were obtained from Sigma-Aldrich. Site-directed mutagenesis utilized the Phusion kit (New England Biolabs, Ipswich, MA). Antibodies against NPC1 (5 μg/ml for IF, 1 μg/ml for WB, ab108921), LAMP1 (1:10 for IF, ab25630), SREBP1 (1:100 for IF, ab28481) and cathepsin B (1 μg/ml for IF, ab6313) were obtained from Abcam (Boston, MA). filipin (f9765) was obtained from Sigma-Aldrich. NBD-cholesterol (N1148) was obtained from Invitrogen (Waltham, MA). BacMAM-ER (C10590) was obtained from Thermo Fisher Scientific (Waltham, MA). Nocodazole (M1404) and taxol (T7402) were obtained from Sigma-Aldrich. The sequences of oligonucleotides used in this study are provided in Table S3.
+ Open protocol
+ Expand
3

NPC1 Protein Deglycosylation Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were homogenized in lysis buffer (50 mM Tris‐HCl pH = 8.0, 150 mM NaCl, 2 mM EDTA, 0.5% Nonidet P‐40 supplemented with proteinase inhibitors), resuspended and centrifuged at 1000 g for 10 min at 4°C. The supernatants’ protein contents were quantified, separated on 4%–12% precast gels Bis‐Tris (NuPAGE, Invitrogen, Carlsbad, CA) subjected to SDS‐PAGE (20 µg of total protein) and semi‐dry transferred to nitrocellulose membranes (Whatman, GE Healthcare, Marlborough, MA). For enzymatic deglycosylation of proteins, cell extracts were incubated in the presence or absence of 1 unit of PNGase F and Endo H (NEB, Ipswich, MA) for 1 h at 37°C according to the manufacturer's instructions. NPC1 protein was detected by incubation with anti‐NPC1 rabbit polyclonal antibody (ab108921, Abcam, Burlingame, CA) overnight and horseradish peroxidase (HRP)—conjugated IgG as the secondary antibody (sc 2313, Santa Cruz Technologies, Santa Cruz, CA). Signal was developed using enhanced chemiluminescence (ECL) (GE Healthcare, Marlborough, MA) and visualized on a ChemiDoc™ XRS+ (Bio‐Rad, Hercules, CA). Band intensity was calculated in Image Lab software version 6.0 (Bio‐Rad, Hercules, CA), after background subtraction and are expressed as Endo H‐sensitive/Endo H‐resistant ratios.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!